Wegovy Cut Heart Attack, Stroke Risks by 20%, Study Finds
A Novo Nordisk study claims its Wegovy weight loss drug can reduce the risk of heart attacks, strokes and cardiovascular death by 20%.
A Novo Nordisk study claims its Wegovy weight loss drug can reduce the risk of heart attacks, strokes and cardiovascular death by 20%.
The manufacturers of Ozempic are moving to have a lawsuit over the drug's gastrointestinal side effects dismissed, claiming that it adequately warned users and the medical community.
The FDA has approved a weight loss version of Eli Lilly's diabetes drug, Mounjaro, which will be marketed under the name Zepbound.
An Ozempic class action lawsuit filed in Canada claims the manufacturer knew about the risks of gastroparesis but failed to adequately notify the medical community and patients of the stomach…
European drug regulators, who previously warned Ozempic and similar drugs may be linked to thyroid cancer, now say there is no data to back up the claims of cancer risk.
A new study finds that Qsymia is more cost effective than Ozempic and similar drugs at providing weight loss benefits for obese children.
A class action lawsuit filed in Washington state accuses a state-run health insurer of discrimination for failing to cover her Wegovy weight loss prescription.
Canadian researchers warn that the side effects of Ozempic and similar diabetes drugs being used for weight loss increase the risk of pancreatitis, bowel obstruction and stomach paralysis.
A new report reveals FDA inspectors found a lack of adequate microbial controls at a Novo Nordisk plant in the U.S., which manufactures the active ingredient for Ozempic and Wegovy.
Some anesthesiologists are saying recent ASA guidelines don't go far enough to prevent Ozempic stomach risks during surgery.